Tag Archives: Cantor Fitzgerald

Avino Silver & Gold (ASM) Gets a Buy Rating from Cantor Fitzgerald

In a report issued on June 1, Matthew O’Keefe from Cantor Fitzgerald reiterated a Buy rating on Avino Silver & Gold (NYSE MKT: ASM), with a price target of $1.50. The company’s shares closed last Friday at $0.67. The word

Cantor Fitzgerald Reiterates Overweight on Ziopharm Oncology Shares, Sees 83% Upside For The Stock

In a research report published on 5/29, Cantor Fitzgerald analyst Alethia Young reiterated an Overweight rating on Ziopharm Oncology (NASDAQ:ZIOP)with a price target of $6, which represents a potential upside of 83% from where the stock is currently trading. According

Anavex Life Sciences (AVXL) Receives a Buy from Cantor Fitzgerald

In a report issued on May 10, Charles Duncan from Cantor Fitzgerald reiterated a Buy rating on Anavex Life Sciences (NASDAQ: AVXL), with a price target of $8.00. The company’s shares closed last Monday at $4.06. Anavex Life Sciences has

Cantor Fitzgerald Reiterates a Buy Rating on Proteostasis Therapeutics (PTI)

Cantor Fitzgerald analyst Kristen Kluska reiterated a Buy rating on Proteostasis Therapeutics (NASDAQ: PTI) on May 19 and set a price target of $4.00. The company’s shares closed last Wednesday at $1.38. Proteostasis Therapeutics has an analyst consensus of Moderate

BioDelivery (BDSI) Receives an Overweight from Cantor Fitzgerald

Cantor Fitzgerald analyst Brandon Folkes reiterated an Overweight rating on BioDelivery (NASDAQ: BDSI) on May 7 and set a price target of $8.00. The company’s shares closed last Friday at $4.94. BioDelivery has an analyst consensus of Strong Buy, with

BioDelivery (BDSI) Receives an Overweight from Cantor Fitzgerald

Cantor Fitzgerald analyst Brandon Folkes reiterated an Overweight rating on BioDelivery (NASDAQ: BDSI) on May 7 and set a price target of $8.00. The company’s shares closed last Friday at $4.94. BioDelivery has an analyst consensus of Strong Buy, with